Upcoming Discussion on Head and Neck Cancer Clinical Trials

Several recent clinical trials focused on head and neck cancer have shown great potential. To help clinicians and surgeons stay current on these advances, this year’s Head & Neck Alumni Day focuses on some of these recent developments.

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The CME event will be held on Friday, Nov. 22, 2024, at Cleveland Clinic’s Lerner Research Institute. Attendees will learn about contemporary management strategies for head and neck cancer and the value of a multidisciplinary approach. The day-long event features lectures and panel discussions on updated therapies and new treatment innovations.

A full-packed day

The 2024 Alumni Day follows a similar schedule format as last year’s with three two-hour-long moderated panel discussions. A discussion moderated by course co-director, Natalie Silver, MD, MS, on the “Latest and Greatest Clinical Trials in Curative Mucosal Squamous Cell Cancer,” kicks things off. After a short break, course co-director, Jamie Ku, MD, will moderate a discussion on “Key Impactful Clinical Trials in the Recurrent/Metastatic Setting.” In the afternoon, a panel discussion on, “Recent Innovative Trials in the Non-mucosal Head and Neck Malignancies,” will be moderated by Brandon Prendes, MD.

The panels include head and neck surgeons, otolaryngologists and oncologists from Cleveland Clinic as well as guest speakers from other medical institutions. This year’s guest speakers are Moran Amit, MD, PhD, from the University of Texas MD Anderson Cancer Center; Evan Graboyes, MD, MPH, from Medical University of South Carolina; Ryan Li, MD, MBA, from Oregon Health & Science University; and Samantha Tam, MD, MPH, from Henry Ford Health.

Course takeaways

Attendees can expect to come away from the event with a better understanding of:

The importance of a multidisciplinary approach when treating head and neck cancer.
Modern surgical technique updates.
Modern radiation and chemotherapy strategy updates.
How to recognize and diagnose rare head and neck cancer diagnoses.
How to manage appropriate referral decisions.

The course is tailored towards head and neck surgeons, otolaryngologists, medical oncologists, radiation oncologists, trainees, Advanced Practice Providers, speech-language pathologists and nurses involved in diagnosing and treating head and neck cancer patients.

Course and registration details are available here. The deadline for registration is 2:00 pm (PST), Monday, Nov. 18, 2024. For questions about registrations, please call 216.448.8710 or email cmeregistration@ccf.org.

This activity has been approved for AMA PRA Category 1 Credit™.